Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2014

01-12-2014 | Editorial

Visible signs of insulin resistance: opportunities lost

Authors: G. Nagamani, P. G. Sundararaman, G. R. Sridhar

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2014

Login to get access

Excerpt

The hope of a young physician’s call for “Small fevers are gratefully accepted” can be matched by the despair of the senior physician’s “If only diabetes were a little more symptomatic.” The senior physicians’ hopes can be fulfilled to a certain extent—if only. …
Literature
1.
go back to reference Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrnol Metab. 2014;99:E2412–20.CrossRef Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrnol Metab. 2014;99:E2412–20.CrossRef
2.
go back to reference Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertility Soc J. 2011;16:19–37.CrossRef Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertility Soc J. 2011;16:19–37.CrossRef
3.
go back to reference Ganie MA, Nisar S. Current perspectives of polycystic ovary syndrome (PCOS). JIMSA. 2008;21:161–5. Ganie MA, Nisar S. Current perspectives of polycystic ovary syndrome (PCOS). JIMSA. 2008;21:161–5.
4.
go back to reference Conway G, Dewailly D, Kandarakis ED, Morreale HFE, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171:1–29.CrossRef Conway G, Dewailly D, Kandarakis ED, Morreale HFE, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171:1–29.CrossRef
5.
go back to reference Sridhar GR, Lakshmi G. Sleep and obesity. J Gen Med. 2009;21:54–6. Sridhar GR, Lakshmi G. Sleep and obesity. J Gen Med. 2009;21:54–6.
6.
go back to reference Buxton OM, Cain SW, O’Connor SP, Porter JH, Duffy JF, Wang W, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4:129ra–43. Buxton OM, Cain SW, O’Connor SP, Porter JH, Duffy JF, Wang W, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4:129ra–43.
7.
go back to reference Sridhar GR, Venkata P. Sleep and body weight in diabetes mellitus: a large retrospective analysis from south India. Diab Res Clin Pract. 2006;72:209–11.CrossRef Sridhar GR, Venkata P. Sleep and body weight in diabetes mellitus: a large retrospective analysis from south India. Diab Res Clin Pract. 2006;72:209–11.CrossRef
8.
go back to reference Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes. Diabetes. 2012;61:2369–74.PubMedCentralPubMedCrossRef Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes. Diabetes. 2012;61:2369–74.PubMedCentralPubMedCrossRef
9.
go back to reference Morgan CL, Jones SJ, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012. doi:10.1210/jc.2012-1690. Morgan CL, Jones SJ, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012. doi:10.​1210/​jc.​2012-1690.
10.
go back to reference Salley KES, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Position statement: glucose intolerance in polycystic ovary syndrome—a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546–56.PubMedCrossRef Salley KES, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Position statement: glucose intolerance in polycystic ovary syndrome—a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546–56.PubMedCrossRef
11.
go back to reference Ehrmann DA, Kasza K, Azziz R, Legro S, Ghazzi MN, for the PCOS/Troglitazone Study Group. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:66–71.PubMedCrossRef Ehrmann DA, Kasza K, Azziz R, Legro S, Ghazzi MN, for the PCOS/Troglitazone Study Group. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:66–71.PubMedCrossRef
12.
go back to reference Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2:doi 10.4103/0974-1208.51336 Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2:doi 10.​4103/​0974-1208.​51336
13.
go back to reference Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: a community-based study. Indian J Endocrinol Metab. 2012;16 Suppl 2:S389–92.PubMedCentralPubMed Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: a community-based study. Indian J Endocrinol Metab. 2012;16 Suppl 2:S389–92.PubMedCentralPubMed
14.
go back to reference Zargar AH, Gupta K, Wani AI, Masoodi S, Bashir MI, Laway BA, et al. Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol. 2005;3:35.PubMedCentralPubMedCrossRef Zargar AH, Gupta K, Wani AI, Masoodi S, Bashir MI, Laway BA, et al. Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol. 2005;3:35.PubMedCentralPubMedCrossRef
15.
go back to reference Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013;17:138–45.PubMedCentralPubMedCrossRef Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013;17:138–45.PubMedCentralPubMedCrossRef
16.
go back to reference Sundararaman PG, Manomani R, Sridhar GR, Sridhar V, Sundaravalli A, Umachander M. Risk of atherosclerosis in women with polycystic ovary syndrome: a study from south India. Metab Syndr el Dis. 2004;1:271–5.CrossRef Sundararaman PG, Manomani R, Sridhar GR, Sridhar V, Sundaravalli A, Umachander M. Risk of atherosclerosis in women with polycystic ovary syndrome: a study from south India. Metab Syndr el Dis. 2004;1:271–5.CrossRef
17.
go back to reference Moghetti P, Tosi F, Bonin C, Sarra DD, Fiers T, Kaufman JM, et al. Divergence in insulin resistance in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E628–37.PubMedCrossRef Moghetti P, Tosi F, Bonin C, Sarra DD, Fiers T, Kaufman JM, et al. Divergence in insulin resistance in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E628–37.PubMedCrossRef
18.
go back to reference Jie Q. Pay more attention to ethnic differences in polycystic ovary syndrome phenotypic expression. Chinese Med J. 2013;126:2003–6. Jie Q. Pay more attention to ethnic differences in polycystic ovary syndrome phenotypic expression. Chinese Med J. 2013;126:2003–6.
19.
go back to reference Ganie MA, Marwaha RK, Aggarwal R, Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case–control study. Eur J Endocrinol. 2010;162:1117–22.PubMedCrossRef Ganie MA, Marwaha RK, Aggarwal R, Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case–control study. Eur J Endocrinol. 2010;162:1117–22.PubMedCrossRef
20.
go back to reference Ganie MA, Laway BA, Wani TA, Zargar MA, Nisar S, Ahamed F, et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertile Steril. 2011;95:2039–43.CrossRef Ganie MA, Laway BA, Wani TA, Zargar MA, Nisar S, Ahamed F, et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertile Steril. 2011;95:2039–43.CrossRef
21.
go back to reference Sridhar GR, Nagamani G. Association of polycystic ovary syndrome with anticonvulsant use: a case report. Metabolic Syndr Rel Disorders. 2006;4:215–7.CrossRef Sridhar GR, Nagamani G. Association of polycystic ovary syndrome with anticonvulsant use: a case report. Metabolic Syndr Rel Disorders. 2006;4:215–7.CrossRef
22.
go back to reference Sundararaman PG, Shweta, Sridhar GR. Psychosocial aspects of women with polycystic ovary syndrome from south India. J Assoc Physicians India. 2008;56:945–8.PubMed Sundararaman PG, Shweta, Sridhar GR. Psychosocial aspects of women with polycystic ovary syndrome from south India. J Assoc Physicians India. 2008;56:945–8.PubMed
23.
go back to reference Sridhar GR, Madhu K. Stress in the cause and course of diabetes. Intl J Diab Dev Countries. 2001;21:112–20. Sridhar GR, Madhu K. Stress in the cause and course of diabetes. Intl J Diab Dev Countries. 2001;21:112–20.
24.
go back to reference Farrell K, Antoni M. Insulin resistance, obesity, inflammation and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010;94:1565–74.PubMedCentralPubMedCrossRef Farrell K, Antoni M. Insulin resistance, obesity, inflammation and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010;94:1565–74.PubMedCentralPubMedCrossRef
25.
go back to reference Kaviprasanna S, Saikumar P, Alaguveni T. Insulin resistance as an independent risk factor for the development of dyslipidemia in polycystic ovarian syndrome. Adv Biol Res. 2014;8:53–6. Kaviprasanna S, Saikumar P, Alaguveni T. Insulin resistance as an independent risk factor for the development of dyslipidemia in polycystic ovarian syndrome. Adv Biol Res. 2014;8:53–6.
26.
go back to reference Rajendra Prasad N, Bitla AR, Suchitra MM, Rajagopal G, Sachan A, Srinivasa Rao PVLN. A study on prevalence of abnormal glucose tolerance and correlation of insulin resistance with dyslipidemia in south-Indian women with polycystic ovary syndrome. Intl J Diab Dev Cntr 2014; 34: page numbers to be added Rajendra Prasad N, Bitla AR, Suchitra MM, Rajagopal G, Sachan A, Srinivasa Rao PVLN. A study on prevalence of abnormal glucose tolerance and correlation of insulin resistance with dyslipidemia in south-Indian women with polycystic ovary syndrome. Intl J Diab Dev Cntr 2014; 34: page numbers to be added
28.
go back to reference Chen Z-J, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55–60.PubMedCrossRef Chen Z-J, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55–60.PubMedCrossRef
29.
go back to reference Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44:1020–5.PubMedCrossRef Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44:1020–5.PubMedCrossRef
30.
go back to reference Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrinol Metab. 2014;99:E2412–20.PubMedCrossRef Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrinol Metab. 2014;99:E2412–20.PubMedCrossRef
Metadata
Title
Visible signs of insulin resistance: opportunities lost
Authors
G. Nagamani
P. G. Sundararaman
G. R. Sridhar
Publication date
01-12-2014
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2014
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0262-3

Other articles of this Issue 4/2014

International Journal of Diabetes in Developing Countries 4/2014 Go to the issue